Assessment of Satisfaction with Drug Provision of Antihypertensive Drugs at the Outpatient Level of Privileged Categories of Residens

Abuov Jamil, Kalmakhanov Sundetgali, Seiduanova Laura, Tekmanova Ainur, Toksanbayev Daniyar, Pazilov Sabit, Kemelbekov Kanatzhan


Background: The existing system of outpatient drug provision of citizens allows providing certain categories of citizens and patients with certain types of diseases on a free basis. The purpose of the study is to analysis and evaluate the system of providing preferential categories of citizens with antihypertensive drugs at the level of primary health care. Materials and Methods: To determine the level of satisfaction of citizens with drug provision at the outpatient level, 3118 respondents were interviewed using a questionnaire for persons who received free medicines for the treatment of hypertension. The questionnaire consisted of 20 questions. They were distributed by sex and age criterion. The ratio of male and female respondents was 51.7% and 48.7%, respectively. Results: Thus, the results of a sociological study to study the opinions of the population about the existing system of free outpatient care revealed some organizational and managerial problems. Although that patients with hypertension since 2012 receive drugs for free, 37% noted that they bought at full cost in pharmacies, which should be released free of charge for privileged categories of citizens. Also, 77% of respondents claimed that they were not invited to outpatient organizations to receive drugs. Conclusions: In solving the problems of improving the organization and management, it is necessary to take into account regional peculiarities, which allow, based on the use of a set of methods of analysis and forecasting, to assess the state and trends of development, to identify its strengths and weaknesses, to assess the factors of the external and internal environment.


Antihypertensive drugs; preferential categories of residents; satisfaction assessment; sociological study

Full Text:



Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G,

et al. Better compliance to antihypertensive medications reduces

cardiovascular risk. J Hypertens 2011;29:610-618.

Sabaté E. Adherence to long‐term therapies: evidence for action.

Geneva: World Health Organization, 2018.

Saarti S, Hajj A, Karam L, Jabbour H, Sarkis A, El Osta N,

et al. Association between adherence, treatment satisfaction and

illness perception in hypertensive patients. J Hum Hypertens


Kretchy IA, Owusu‐Daaku FT, Danquah S. Locus of control and

anti‐hypertensive medication adherence in Ghana. Pan Afr Med J

;17(Suppl. 1):13.

Yue Z, Bin W, Weilin Q, Aifang Y. Effect of medication adherence

on blood pressure control and risk factors for antihypertensive

medication adherence. J Eval Clin Pract 2015;21:166-72.

Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG,

Crea F, et al. Guidelines of the management of the stable angina

pectoris: Executive summary: The task force on the management

of stable angina pectoris of the Eur. Heart J. 2006;27:1341-81.

Chiolero A, Burnier M, Santschi V. Improving treatment

satisfaction to increase adherence. J Hum Hypertens


Jackson, G. Combination therapy in angina: review of

combined haemodynamic treatment and the role for combined

haemodynamic and cardiac metabolic agent / G. Jackson // J.

Clin. Pract. 2001;55:256-61.

Jackson, G. Stable angina: maximal medical therapy is not

same as optimal medical therapy / G. Jackson // J Clin. Pract.


Asgedom SW, Gudina EK, Desse TA. Assessment of blood

pressure control among hypertensive patients in Southwest

Ethiopia. PLoS One 2016;11:e0166432.

Lahdenpera, T.S. Development of a scale to assess the

compliance of hypertensive patients / T.S. Lahdenpera, C.C.

Wright, H.A. Kyngas // J Nurs. Stud. 2003;40:677-84.

Lapeyre-Mestre, M. Consumption of antihypertensive agents in

obese patients: a cross sectional study in a sample of 3,291 wage

earners in the Toulouse region / M. Lapeyre-Mestre // Archives

des Maladies du Coeur. 2000;93:925-9.

Ayazbekov A, Nurkhasimova R, Ibrayeva D, Uteuliyev Y,

Kemelbekov K. Evaluation of women's health with intrauterine

fetal death in the city of turkestan for the years of 2013-2017.

Annals of Tropical Medicine and Public Health, 2018, 17(Special

issue), стр. S804.

Kemelbekov K, Dzhoshibaev S, Baymagambetov A, Satymbekova

A, Sheyshenov Z. Epidemiology and dynamics of congenital heart

diseases at the newborns in the Zhambyl region, Kazakhstan. Research Journal of Medical Sciences, 2016;10:69-75.

Ayazbekov A, Nurkhasimova R, Kulbayeva S,

Sarbassova M, Kemelbekov KS. Features of pregnancy,

childbirth and postpartum period of young mothers. Electronic

Journal of General Medicine, 2020;17:1-8, em260.

Rowan CG, Turner JR, Shah A, Spaeder JA. Antihypertensive

treatment and blood pressure control relative to hypertension

treatment guidelines. Pharmacoepidemiol Drug Saf.


O'Rourke, R.A. Optimal medical management of patients with

chronic ischemic heart disease / R.A. O'Rourke // Curr Probl in

Cardiol. 2001;26:193-238.

Ahmad N, Hassan Y, Tangiisuran B, Meng OL, Aziz NA,

Ahmad F, et al., Guidelines adherence and hypertension control

at a tertiary hospital in Malaysia. Journal Of Evaluation In

Clinical Practice, 2012:1-7.

Abdalwahed S. Physician adherence to hypertension treatment

guidelines and drug acquisition costs of antihypertensive drugs at the

cardiac clinic: a pilot study. Patient Prefer Adherence. 2012;6:101-8.

Prevalence treatment, control of hypertension in General practice

in France / B. Chamontin, J.M. Mallion, T. Lang et al. // Can. J

Cardiol. 1997;13:1267.

Shukrala F, Gabriel T. Assessment of prescribing, dispensing,

and patient use pattern of antihypertensive drugs for patients

attending outpatient department of Hiwot Fana Specialized

University Hospital, Harar, Eastern Ethiopia. Drug Des Devel

Ther. 2015;9:519-23.

Mateo C, Gil A, Sevillano ML, Barutell L, Lorenzo A, Pérez

de Lucas N. Quality of antihypertensive drug prescription in a

health area. Aten Primaria 2000;31:302-7.

Zanchetti A, Hansson L, Menard J, Leonetti G, Rahn KH,

Warnold I, et al. Risk assessment and treatment benefit in

intensivly treated hypertensive patients of the hypertension

optimal treatment (HOT) study. J Hypertens 2001;19:819-25.

Saruta, T. Hypertension in Japan / T. Saruta // Nikkei Medical.


Ko MJ, Park CM, Kim YJ, Kang SH, Park DW. Clinical

application and potential effects of 2014 hypertension guidelines

on incident cardiovascular events. Am Heart J. 2015;170:1042–